BAY CITY CAPITAL LLC → MADRIGAL PHARMACEUTICALS, INC. MDGL

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 20/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (7.2 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

0 buys · 1 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 7.24

2,194,545 shares short · -8.4% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $79.63M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-06-01	Soergel David	officer	Sale	1,042	$495.74	$517K

Other 13D/G Filings on MADRIGAL PHARMACEUTICALS, INC.

Filed	Form	Filer	Stake	Shares
2023-10-05	SC	BAKER BROS. ADVISORS LP	—	—	view →
2020-09-08	SC	BAY CITY CAPITAL LLC	—	—	view →
2020-06-01	SC	BAY CITY CAPITAL LLC	—	—	view →
2019-10-17	SC	BAY CITY CAPITAL LLC	—	—	view →
2019-10-17	SC	Taub Rebecca	—	—	view →
2019-10-17	SC	FRIEDMAN PAUL A	—	—	view →

Other Filings by BAY CITY CAPITAL LLC

Filed	Form	Issuer	Stake	Shares
2020-09-08	SC	MADRIGAL PHARMACEUTICALS, INC. MDGL	—	—	view →
2020-06-01	SC	MADRIGAL PHARMACEUTICALS, INC. MDGL	—	—	view →
2020-02-24	SC	Dermira, Inc.	—	—	view →
2020-01-13	SC	Dermira, Inc.	—	—	view →
2019-10-17	SC	MADRIGAL PHARMACEUTICALS, INC. MDGL	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →